市場調査レポート
商品コード
1397376

睡眠時無呼吸症候群用口腔内装置の世界市場 (~2028年):製品タイプ (MAD・TRD)・購入タイプ (医師処方)・性別 (男性・女性)・年齢層・流通チャネル (オンライン・小売) 別

Sleep Apnea Oral Appliances Market by Product (Mandibular Advancement Devices (MAD), Tongue-Retaining Devices (TRD)), Purchase Type (Physician-prescribed), Gender (Male, Female), Age Group, Distribution Channel (Online, Retail) - Global Forecast to 2028

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 201 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
睡眠時無呼吸症候群用口腔内装置の世界市場 (~2028年):製品タイプ (MAD・TRD)・購入タイプ (医師処方)・性別 (男性・女性)・年齢層・流通チャネル (オンライン・小売) 別
出版日: 2023年12月12日
発行: MarketsandMarkets
ページ情報: 英文 201 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

レポート概要

調査範囲
調査対象年 2021-2028年
基準年 2022年
予測期間 2023-2028年
単位 金額 (米ドル)
セグメント 製品タイプ・購入タイプ・性別・年齢層・流通チャネル・エンドユーザー
対象地域 北米・欧州・アジア太平洋・その他の地域

世界の睡眠時無呼吸症候群用口腔内装置の市場規模は、2023年の4億米ドルから、予測期間中は15.2%のCAGRで推移し、2028年には9億米ドルの規模に成長すると予測されています。

同市場の成長は、睡眠クリニックの増加と生活習慣病の増加が主な要因です。しかし一方で、代替療法や薬物療法が同市場の成長を抑制する可能性があります。

製品タイプ別では、下顎前方移動型 (MAD) の部門が高いシェアを示しています。MADは、良好な臨床結果とCPAP療法に耐えられない患者に対する医師の推奨により、市場を独占すると考えられています。

購入タイプ別では、医師処方/カスタマイズの部門が2022年に最大のシェアを示し、予測期間中は最大のCAGRを示す見通しです。同部門の成長を支える要因には、軽度から中等度の睡眠時無呼吸症候群を治療するための医師による口腔内装置の推奨の高まりが含まれます。

地域別では、アジア太平洋地域が予測期間中に最大の成長率を示す見通しです。同地域市場は、肥満、座りがちな生活、食生活の変化などの生活習慣病が睡眠時無呼吸症候群の発生率を高めているため、予測期間中に高い成長が見込まれています。

当レポートでは、世界の睡眠時無呼吸症候群用口腔内装置の市場を調査し、市場概要、市場成長への各種影響因子および市場機会の分析、技術・特許の動向、法規制環境、市場規模の推移・予測、各種区分・地域別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
  • 価格分析
  • バリューチェーン分析
  • サプライチェーン分析
  • ポーターのファイブフォース分析
  • エコシステム分析
  • 規制分析
  • 特許分析
  • 顧客の事業に影響を与える動向・ディスラプション
  • 主な会議とイベント
  • 技術分析
  • 主なステークホルダーと購入基準
  • 貿易分析

第6章 エンドユーザーの認識分析

  • 現在の製品タイプの利点と制約
  • 購入の意思決定プロセス

第7章 睡眠時無呼吸症候群用口腔内装置市場:製品別

  • 下顎前方前進装置 (MAD)
    • 既製MAD
    • カスタムメイドMAD
  • 舌前方維持装置 (TRD)
  • 昼夜兼用装置

第8章 睡眠時無呼吸症候群用口腔内装置市場:性別

  • 男性
  • 女性

第9章 睡眠時無呼吸症候群用口腔内装置市場:購入タイプ別

  • 医師処方/カスタマイズ口腔内装置
  • オンラインOTC口腔内装置

第10章 睡眠時無呼吸症候群用口腔内装置市場:年齢層別

  • 40歳未満
  • 40~60歳
  • 60歳超

第11章 睡眠時無呼吸症候群用口腔内装置市場:流通チャネル別

  • オンライン薬局
  • 小売薬局
  • 病院薬局・歯科医院

第12章 睡眠時無呼吸症候群用口腔内装置市場:エンドユーザー別

  • 在宅ケア・個人
  • 病院
  • 歯科医院

第13章 睡眠時無呼吸症候群用口腔内装置市場:地域別

  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第14章 競合情勢

  • 概要
  • 主要企業の戦略
  • 収益分析
  • 市場シェア分析
  • 企業評価マトリックス
  • 新興企業/中小企業の評価マトリックス
  • 競合シナリオ

第15章 企業プロファイル

  • 主要企業
    • SOMNOMED
    • RESMED
    • PROSOMNUS SLEEP TECHNOLOGIES
    • WHOLE YOU, INC.
    • VIVOS THERAPEUTICS, INC.
    • OPEN AIRWAY DENTAL SOLUTIONS LTD.
    • PANTHERA DENTAL
    • AIRWAY MANAGEMENT
    • APNEA SCIENCES
    • DYNAFLEX
    • ORAVANOSA
    • MYERSON LLC
  • その他の企業
    • MPOWRX HEALTH & WELLNESS
    • THE SNORE RELIEVER COMPANY, LLC
    • THE PURE SLEEP COMPANY
    • TOMED GMBH
    • THE AURUM GROUP
    • ERKODENT ERICH KOPP GMBH
    • OSCIMED SA
    • SICAT GMBH & CO. KG
    • GLIDEWELL
    • APNOMED
    • ZYPPAH
    • DREAM SYSTEMS DENTAL SLEEP LABORATORY
    • ALIVE MED

第16章 付録

目次
Product Code: MD 6285

Report Description

Scope of the Report
Years Considered for the Study2021-2028
Base Year2022
Forecast Period2023-2028
Units ConsideredValue (USD) Billion
SegmentsProduct, Purchase Type, Gender, Age group, Distribution Channel and End User
Regions coveredNorth America, Europe, Asia Pacific, and Rest of the World

The global sleep apnea oral appliance market is projected to reach USD 0.9 Billion by 2028 from USD 0.4 Billion in 2023, at a CAGR of 15.2% during the forecast period. The growth of this market is majorly driven by the rising number of sleep clinics and increasing lifestyle-related disorders. However, alternative therapies and medication may restrain the growth of the sleep apnea oral appliance market.

"Higher adoption of mandibular advancement devices accounts for highest market share in sleep apnea oral appliances market"

Based on the product segment, the sleep apnea oral appliance market is categorized into mandibular advancement devices, tongue retaining devices and daytime nighttime appliances. Mandibular advancement devices is said to dominate sleep apnea oral appliances market due to positive clinical outcomes and recommendation from doctors for patients not compying to CPAP therapy.

"Physician-prescribed/ customized oral appliance segment accounted for the highest CAGR."

Base on purchase type, the sleep apnea oral appliances market is segmented into - physician-prescribed/ customized oral appliances and online OTC oral appliances. The physician-prescribed/customized oral appliances segment dominated sleep apnea oral appliances market with the largest share in 2022. Factors supporting the growth of this segment include rising recommendation of oral appliances by physicians for treating mild to moderate sleep apnea.

"The Asia Pacific segment accounted for the highest growth rate in the sleep apnea oral appliance systems market, by region, during the forecast period."

The global sleep apnea oral appliances market has been segmented into four major regions-North America, Europe, the Asia Pacific, and the Rest of the World. The sleep apnea oral appliances market in several Aisa Pacific countries is expected to witness high growth during the forecast period owing to the lifestyle disoders such as obesity, sedentary lifestyles, and changes in dietary habits leading to higher incidence of sleep apnea in the region.

Breakdown of supply-side primary interviews, by company type, designation, and region:

  • By Company Type: Tier 1 (40%), Tier 2 (50%), and Tier 3 (10%)
  • By Designation: C-level (48%), Director-level (37%), and Others (15%)
  • By Region: North America (56%), Europe (20%), Asia- Pacific (17%), and Rest of the World (7%)

Prominent companies include SomnoMed (Australia), ResMed (US), Whole You, Inc. (US), ProSomnus Sleep Technologies (US), Vivos Therapeutics, Inc. (US), Open Airway Dental Solutions Ltd. (Canada), Panthera Dental (Canada), Airway Management (US), Apnea Sciences (US), DynaFlex (US), OravanOSA (US), Myerson LLC (US), MPowrx Health & Wellness (Canada), The Snore Reliever Company, LLC (US), The Pure Sleep Company (US), Tomed GmbH (Germany), The Aurum Group (Canada), Erkodent Erich Kopp GmbH (Germany), OSCIMED SA (Switzerland), SICAT GmbH & Co. Kg. (Germany), Glidewell (US), ApnoMed (US), ZYPPAH (US), Dream Systems Dental Sleep Laboratory (US), and Alive Med (UAE).

Research Coverage

This research report categorizes the sleep apnea oral appliance market by product (mandibular advancement devices, tongue-retaining devices, and daytime nighttime appliances) by type (physician-prescribed/customized oral appliance, and online OTC appliances), by gender (male, and female), by age (below 40 years, age 40-60 years, and above 60 years), by distribution channel (online pharmacies, retail pharmacies and hospital pharmacies and dental clinics), by end user (homecare settings, hospitals, and dental clinics) and region (North America, Europe, Asia Pacific, and Rest of the World). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the sleep apnea oral appliance market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; Contracts, partnerships, agreements. New product & service launches, mergers and acquisitions, and recent developments associated with the sleep apnea oral appliance market. Competitive analysis of upcoming startups in the sleep apnea oral appliance market ecosystem is covered in this report.

Key Benefits of Buying the Report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall sleep apnea oral appliance market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

  • Analysis of key drivers (large pool of undiagnosed sleep apnea patients, growing awareness of effects of untreated sleep apnea, growing usage of oral appliance), restraints (high prices of customized oral appliances, alternative therapies and medications, risks associated with oral appliance therapy for obstructive sleep apnea), opportunities (growing demand for home sleep apnea tests, increasing focus on telemedicine, mHealth, and AI, poor compliance associated with CPAP), and challenges (complex referral pathways and long waiting periods) influencing the growth of the sleep apnea oral appliance market.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the sleep apnea oral appliance market.
  • Market Development: Comprehensive information about lucrative markets - the report analyses the sleep apnea oral appliance market across varied regions.
  • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the sleep apnea oral appliance market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like SomnoMed (Australia), ResMed (US), and ProSomnus Sleep Technologies (US), among others in the sleep apnea oral appliance market strategies.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • TABLE 1 INCLUSIONS & EXCLUSIONS
  • 1.3 STUDY SCOPE
    • FIGURE 1 SLEEP APNEA ORAL APPLIANCES MARKET SCOPE
    • 1.3.1 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 2 SLEEP APNEA ORAL APPLIANCES MARKET: RESEARCH DESIGN METHODOLOGY
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
    • FIGURE 3 PRIMARY SOURCES
    • 2.1.3 KEY INDUSTRY INSIGHTS
      • 2.1.3.1 Key data from primary sources
      • 2.1.3.2 Breakdown of primary interviews
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 BOTTOM-UP APPROACH
      • 2.2.1.1 Approach 1: Company revenue estimation approach
    • FIGURE 5 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
      • 2.2.1.2 Approach 2: Presentations of companies and primary interviews
      • 2.2.1.3 Approach 3: Patient-based approach
    • FIGURE 6 BOTTOM-UP APPROACH: PATIENT-BASED ANALYSIS
      • 2.2.1.4 Growth forecast
      • 2.2.1.5 CAGR projections
    • FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    • 2.2.2 TOP-DOWN APPROACH
    • FIGURE 8 SLEEP APNEA ORAL APPLIANCES MARKET: TOP-DOWN APPROACH
  • 2.3 DATA TRIANGULATION
    • FIGURE 9 DATA TRIANGULATION METHODOLOGY
  • 2.4 RESEARCH ASSUMPTIONS
  • 2.5 LIMITATIONS AND RISK ASSESSMENT
    • TABLE 2 RISK ASSESSMENT: SLEEP APNEA ORAL APPLIANCES MARKET
  • 2.6 IMPACT OF RECESSION ON SLEEP APNEA ORAL APPLIANCES MARKET

3 EXECUTIVE SUMMARY

    • FIGURE 10 SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
    • FIGURE 11 SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 12 SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2023 VS. 2028 (USD MILLION)
    • FIGURE 13 SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2023 VS. 2028 (USD MILLION)
    • FIGURE 14 SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2023 VS. 2028 (USD MILLION)
    • FIGURE 15 SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    • FIGURE 16 SLEEP APNEA ORAL APPLIANCES MARKET, BY REGION, 2023 VS. 2028 (USD MILLION)

4 PREMIUM INSIGHTS

  • 4.1 SLEEP APNEA ORAL APPLIANCES MARKET OVERVIEW
    • FIGURE 17 LARGE POOL OF UNDIAGNOSED SLEEP APNEA PATIENTS TO DRIVE MARKET FOR SLEEP APNEA ORAL APPLIANCES
  • 4.2 SLEEP APNEA ORAL APPLIANCES MARKET, BY REGION (2023-2028)
    • FIGURE 18 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • 4.3 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT AND COUNTRY (2021)
    • FIGURE 19 US ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN SLEEP APNEA ORAL APPLIANCES MARKET IN 2022
  • 4.4 SLEEP APNEA ORAL APPLIANCES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 20 COUNTRIES IN ASIA PACIFIC TO GROW AT HIGHER RATES DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 21 SLEEP APNEA ORAL APPLIANCES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Large pool of undiagnosed sleep apnea patients
    • TABLE 3 PREVALENCE OF SLEEP APNEA IN 2020
      • 5.2.1.2 Growing awareness of effects of untreated sleep apnea
    • TABLE 4 INITIATIVES TO PROMOTE AWARENESS ABOUT EFFECTS OF UNTREATED SLEEP APNEA
      • 5.2.1.3 Growing usage of oral appliances
    • TABLE 5 LIST OF ADVANCED ORAL APPLIANCES AVAILABLE FOR TREATING SLEEP APNEA
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High prices of customized oral appliances
      • 5.2.2.2 Alternative therapies and medications
      • 5.2.2.3 Risks associated with oral appliance therapy for obstructive sleep apnea
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growing demand for home sleep apnea tests
      • 5.2.3.2 Increasing focus on telemedicine, mHealth, and AI
      • 5.2.3.3 Poor compliance associated with CPAP
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Complex referral pathways and long waiting periods
  • 5.3 PRICING ANALYSIS
    • TABLE 6 AVERAGE SELLING PRICE OF SLEEP APNEA ORAL APPLIANCES
  • 5.4 VALUE CHAIN ANALYSIS
    • FIGURE 22 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
  • 5.5 SUPPLY CHAIN ANALYSIS
    • FIGURE 23 DIRECT DISTRIBUTION-PREFERRED STRATEGY OF PROMINENT COMPANIES
  • 5.6 PORTER'S FIVE FORCES ANALYSIS
    • 5.6.1 THREAT OF NEW ENTRANTS
    • 5.6.2 THREAT OF SUBSTITUTES
    • 5.6.3 BARGAINING POWER OF SUPPLIERS
    • 5.6.4 BARGAINING POWER OF BUYERS
    • 5.6.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.7 ECOSYSTEM ANALYSIS
    • FIGURE 24 SLEEP APNEA ORAL APPLIANCES MARKET: ECOSYSTEM ANALYSIS
    • 5.7.1 ROLE IN ECOSYSTEM
    • FIGURE 25 KEY PLAYERS IN SLEEP APNEA ORAL APPLIANCES MARKET ECOSYSTEM
  • 5.8 REGULATORY ANALYSIS
    • TABLE 7 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING SLEEP APNEA DEVICES
    • 5.8.1 NORTH AMERICA
      • 5.8.1.1 US
    • TABLE 8 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
      • 5.8.1.2 Canada
    • TABLE 9 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
    • 5.8.2 EUROPE
    • 5.8.3 ASIA PACIFIC
      • 5.8.3.1 Japan
    • TABLE 10 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
      • 5.8.3.2 China
    • TABLE 11 CHINA: CLASSIFICATION OF MEDICAL DEVICES
      • 5.8.3.3 India
      • 5.8.3.4 Australia
  • 5.9 PATENT ANALYSIS
    • 5.9.1 PATENT TRENDS FOR SLEEP APNEA ORAL APPLIANCES
    • FIGURE 26 PATENT TRENDS FOR SLEEP APNEA ORAL APPLIANCES, JANUARY 2011-OCTOBER 2023
    • 5.9.2 JURISDICTION AND TOP APPLICANT ANALYSIS
    • FIGURE 27 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR SLEEP APNEA ORAL APPLIANCE PATENTS, JANUARY 2011-OCTOBER 2023
  • 5.10 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • 5.10.1 REVENUE SHIFT & REVENUE POCKETS FOR SLEEP APNEA ORAL APPLIANCE MANUFACTURERS
    • FIGURE 28 REVENUE SHIFT FOR SLEEP APNEA ORAL APPLIANCES
  • 5.11 KEY CONFERENCES & EVENTS IN 2023-2024
    • TABLE 12 SLEEP APNEA ORAL APPLIANCES MARKET: DETAILED LIST OF CONFERENCES & EVENTS
  • 5.12 TECHNOLOGY ANALYSIS
  • 5.13 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SLEEP APNEA ORAL APPLIANCES
    • TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SLEEP APNEA ORAL APPLIANCES (%)
    • 5.13.2 BUYING CRITERIA
    • FIGURE 30 KEY BUYING CRITERIA FOR END USERS OF SLEEP APNEA ORAL APPLIANCES
    • TABLE 14 KEY BUYING CRITERIA FOR END USERS OF SLEEP APNEA ORAL APPLIANCES
  • 5.14 TRADE ANALYSIS
    • TABLE 15 IMPORT DATA FOR HS CODE 901849, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 16 EXPORT DATA FOR HS CODE 901849, BY COUNTRY, 2018-2022 (USD MILLION)

6 END-USER PERCEPTION ANALYSIS

  • 6.1 BENEFITS AND LIMITATIONS OF CURRENT PRODUCT TYPES
  • 6.2 BUYING DECISION-MAKING PROCESS
    • 6.2.1 INTRODUCTION
      • 6.2.1.1 Need recognition
      • 6.2.1.2 Gathering information
      • 6.2.1.3 Evaluating alternatives
        • 6.2.1.3.1 Product features: comparative assessment
      • 6.2.1.4 Need gap analysis

7 SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT

  • 7.1 INTRODUCTION
    • TABLE 17 SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • 7.2 MANDIBULAR ADVANCEMENT DEVICES
    • TABLE 18 MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 19 MANDIBULAR ADVANCEMENT DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 7.2.1 READY-MADE MANDIBULAR ADVANCEMENT DEVICES
      • 7.2.1.1 Low cost of readymade MADS to drive demand
    • TABLE 20 READY-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 7.2.2 CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES
      • 7.2.2.1 Increasing efficacy of custom-made MADs to drive market growth
    • TABLE 21 CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 7.3 TONGUE-RETAINING DEVICES
    • 7.3.1 LOWER SUCCESS RATE OF TRDS TO CHALLENGE MARKET GROWTH
    • TABLE 22 TONGUE-RETAINING DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 7.4 DAYTIME-NIGHTTIME APPLIANCES
    • 7.4.1 HIGHER COMFORT OF DNAS TO DRIVE ADOPTION
    • TABLE 23 DAYTIME-NIGHTTIME APPLIANCES MARKET, BY REGION, 2021-2028 (USD MILLION)

8 SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER

  • 8.1 INTRODUCTION
    • TABLE 24 SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2021-2028 (USD MILLION)
  • 8.2 MALES
    • 8.2.1 HIGHER PREVALENCE OF OSA IN MALES TO BOOST MARKET GROWTH
    • TABLE 25 SLEEP APNEA ORAL APPLIANCES MARKET FOR MALES, BY REGION, 2021-2028 (USD MILLION)
  • 8.3 FEMALES
    • 8.3.1 OSA UNDERDIAGNOSIS IN FEMALES TO RESTRICT MARKET GROWTH
    • TABLE 26 SLEEP APNEA ORAL APPLIANCES MARKET FOR FEMALES, BY REGION, 2021-2028 (USD MILLION)

9 SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE

  • 9.1 INTRODUCTION
    • TABLE 27 SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2021-2028 (USD MILLION)
  • 9.2 PHYSICIAN-PRESCRIBED/CUSTOMIZED ORAL APPLIANCES
    • 9.2.1 FAILURE OF CPAP THERAPY TO DRIVE DEMAND FOR PHYSICIAN-PRESCRIBED ORAL APPLIANCES
    • TABLE 28 PHYSICIAN-PRESCRIBED/CUSTOMIZED ORAL APPLIANCES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 9.3 ONLINE OTC ORAL APPLIANCES
    • 9.3.1 LACK OF REGULATORY APPROVAL TO HINDER MARKET GROWTH
    • TABLE 29 ONLINE OTC ORAL APPLIANCES MARKET, BY REGION, 2021-2028 (USD MILLION)

10 SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP

  • 10.1 INTRODUCTION
    • TABLE 30 SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
  • 10.2 BELOW 40 YEARS
    • 10.2.1 LOWER PREVALENCE OF SLEEP APNEA IN YOUNGER AGE GROUPS TO RESTRICT MARKET GROWTH
    • TABLE 31 SLEEP APNEA ORAL APPLIANCES MARKET FOR BELOW 40 AGE GROUP, BY REGION, 2021-2028 (USD MILLION)
  • 10.3 40-60 YEARS
    • 10.3.1 LIFESTYLE FACTORS TO CONTRIBUTE TO MARKET GROWTH
    • TABLE 32 SLEEP APNEA ORAL APPLIANCES MARKET FOR 40-60 AGE GROUP, BY REGION, 2021-2028 (USD MILLION)
  • 10.4 ABOVE 60 YEARS
    • 10.4.1 INCREASING BREATHING DISTURBANCES AND SLEEP APNEA TO IMPACT MARKET GROWTH
    • TABLE 33 PREVALENCE OF SLEEP APNEA, BY AGE GROUP
    • TABLE 34 SLEEP APNEA ORAL APPLIANCES MARKET FOR ABOVE 60 AGE GROUP, BY REGION, 2021-2028 (USD MILLION)

11 SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL

  • 11.1 INTRODUCTION
    • TABLE 35 SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • 11.2 ONLINE PHARMACIES
    • 11.2.1 GROWING PREFERENCE FOR DIRECT DISTRIBUTION CHANNELS TO DRIVE MARKET
    • TABLE 36 SLEEP APNEA ORAL APPLIANCES MARKET FOR ONLINE PHARMACIES, BY REGION, 2021-2028 (USD MILLION)
  • 11.3 RETAIL PHARMACIES
    • 11.3.1 EASY ACCESS TO PRODUCTS TO BOOST MARKET
    • TABLE 37 SLEEP APNEA ORAL APPLIANCES MARKET FOR RETAIL PHARMACIES, BY REGION, 2021-2028 (USD MILLION)
  • 11.4 HOSPITAL PHARMACIES & DENTAL CLINICS
    • 11.4.1 HIGH PATIENT CONVENIENCE IN HOSPITAL PHARMACIES TO DRIVE DEMAND
    • TABLE 38 SLEEP APNEA ORAL APPLIANCES MARKET FOR HOSPITAL PHARMACIES & DENTAL CLINICS, BY REGION, 2021-2028 (USD MILLION)

12 SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER

  • 12.1 INTRODUCTION
    • TABLE 39 SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 12.2 HOME CARE SETTINGS/INDIVIDUALS
    • 12.2.1 RISING PATIENT PREFERENCE FOR ADVANCED HOME SLEEP CARE DEVICES TO DRIVE MARKET
    • TABLE 40 SLEEP APNEA ORAL APPLIANCES MARKET FOR HOME CARE SETTINGS/INDIVIDUALS, BY REGION, 2021-2028 (USD MILLION)
  • 12.3 HOSPITALS
    • 12.3.1 RAPID DEVELOPMENT IN HEALTHCARE INFRASTRUCTURE TO DRIVE DEMAND FOR ORAL APPLIANCES IN HOSPITALS
    • TABLE 41 SLEEP APNEA ORAL APPLIANCES MARKET FOR HOSPITALS, BY REGION, 2021-2028 (USD MILLION)
  • 12.4 DENTAL CLINICS
    • 12.4.1 RISING NUMBER OF DENTAL CLINICS TO BOOST MARKET GROWTH
    • TABLE 42 SLEEP APNEA ORAL APPLIANCES MARKET FOR DENTAL CLINICS, BY REGION, 2021-2028 (USD MILLION)

13 SLEEP APNEA ORAL APPLIANCES MARKET, BY REGION

  • 13.1 INTRODUCTION
    • TABLE 43 SLEEP APNEA ORAL APPLIANCES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 13.2 NORTH AMERICA
    • 13.2.1 NORTH AMERICA: RECESSION IMPACT
    • FIGURE 31 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET SNAPSHOT
    • TABLE 44 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 45 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 46 NORTH AMERICA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 47 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2021-2028 (USD MILLION)
    • TABLE 48 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2021-2028 (USD MILLION)
    • TABLE 49 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 50 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
    • TABLE 51 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 13.2.2 US
      • 13.2.2.1 US to dominate North American market during forecast period
    • TABLE 52 US: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 53 US: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 54 US: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2021-2028 (USD MILLION)
    • TABLE 55 US: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2021-2028 (USD MILLION)
    • TABLE 56 US: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 57 US: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
    • TABLE 58 US: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 13.2.3 CANADA
      • 13.2.3.1 Large pool of undiagnosed patients to drive market growth.
    • TABLE 59 CANADA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 60 CANADA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 61 CANADA: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2021-2028 (USD MILLION)
    • TABLE 62 CANADA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2021-2028 (USD MILLION)
    • TABLE 63 CANADA: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 64 CANADA: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
    • TABLE 65 CANADA: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 13.3 EUROPE
    • 13.3.1 EUROPE: RECESSION IMPACT
    • TABLE 66 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 67 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 68 EUROPE: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 69 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2021-2028 (USD MILLION)
    • TABLE 70 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2021-2028 (USD MILLION)
    • TABLE 71 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 72 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
    • TABLE 73 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 13.3.2 GERMANY
      • 13.3.2.1 High prevalence of OSA in Germany to boost market
    • TABLE 74 GERMANY: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 75 GERMANY: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 76 GERMANY: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2021-2028 (USD MILLION)
    • TABLE 77 GERMANY: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2021-2028 (USD MILLION)
    • TABLE 78 GERMANY: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 79 GERMANY: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
    • TABLE 80 GERMANY: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 13.3.3 FRANCE
      • 13.3.3.1 Rising geriatric population to increase incidence of sleep apnea in France
    • TABLE 81 FRANCE: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 82 FRANCE: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 83 FRANCE: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2021-2028 (USD MILLION)
    • TABLE 84 FRANCE: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2021-2028 (USD MILLION)
    • TABLE 85 FRANCE: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 86 FRANCE: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
    • TABLE 87 FRANCE: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 13.3.4 UK
      • 13.3.4.1 Rising awareness initiatives and sleep service groups to support market growth in UK
    • TABLE 88 UK: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 89 UK: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 90 UK: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2021-2028 (USD MILLION)
    • TABLE 91 UK: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2021-2028 (USD MILLION)
    • TABLE 92 UK: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 93 UK: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
    • TABLE 94 UK: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 13.3.5 ITALY
      • 13.3.5.1 Growing sleep disorder patient population to drive demand for oral appliances in Italy
    • TABLE 95 ITALY: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 96 ITALY: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 97 ITALY: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2021-2028 (USD MILLION)
    • TABLE 98 ITALY: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2021-2028 (USD MILLION)
    • TABLE 99 ITALY: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 100 ITALY: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
    • TABLE 101 ITALY: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 13.3.6 SPAIN
      • 13.3.6.1 Low social awareness about sleep apnea and treatment options to challenge market growth
    • TABLE 102 SPAIN: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 103 SPAIN: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 104 SPAIN: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2021-2028 (USD MILLION)
    • TABLE 105 SPAIN: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2021-2028 (USD MILLION)
    • TABLE 106 SPAIN: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 107 SPAIN: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
    • TABLE 108 SPAIN: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 13.3.7 REST OF EUROPE
    • TABLE 109 REST OF EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 110 REST OF EUROPE: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 111 REST OF EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2021-2028 (USD MILLION)
    • TABLE 112 REST OF EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2021-2028 (USD MILLION)
    • TABLE 113 REST OF EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 114 REST OF EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
    • TABLE 115 REST OF EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 13.4 ASIA PACIFIC
    • 13.4.1 ASIA PACIFIC: RECESSION IMPACT
    • FIGURE 32 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET SNAPSHOT
    • TABLE 116 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 117 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 118 ASIA PACIFIC: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 119 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2021-2028 (USD MILLION)
    • TABLE 120 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2021-2028 (USD MILLION)
    • TABLE 121 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 122 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
    • TABLE 123 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 13.4.2 JAPAN
      • 13.4.2.1 Poor reimbursement scenario in Japan to restrain market growth
    • TABLE 124 JAPAN: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 125 JAPAN: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 126 JAPAN: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2021-2028 (USD MILLION)
    • TABLE 127 JAPAN: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2021-2028 (USD MILLION)
    • TABLE 128 JAPAN: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 129 JAPAN: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
    • TABLE 130 JAPAN: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 13.4.3 CHINA
      • 13.4.3.1 Increasing diagnostics market in China to raise demand for appliances.
    • TABLE 131 CHINA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 132 CHINA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 133 CHINA: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2021-2028 (USD MILLION)
    • TABLE 134 CHINA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2021-2028 (USD MILLION)
    • TABLE 135 CHINA: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 136 CHINA: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
    • TABLE 137 CHINA: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 13.4.4 AUSTRALIA
      • 13.4.4.1 Rising number of domestic manufacturers of oral appliances to drive demand in Australia
    • TABLE 138 AUSTRALIA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 139 AUSTRALIA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 140 AUSTRALIA: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2021-2028 (USD MILLION)
    • TABLE 141 AUSTRALIA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2021-2028 (USD MILLION)
    • TABLE 142 AUSTRALIA: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 143 AUSTRALIA: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
    • TABLE 144 AUSTRALIA: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 13.4.5 REST OF ASIA PACIFIC
    • TABLE 145 REST OF ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 146 REST OF ASIA PACIFIC: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 147 REST OF ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2021-2028 (USD MILLION)
    • TABLE 148 REST OF ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2021-2028 (USD MILLION)
    • TABLE 149 REST OF ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 150 REST OF ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
    • TABLE 151 REST OF ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 13.5 REST OF THE WORLD
    • 13.5.1 LATIN AMERICA: RECESSION IMPACT
    • 13.5.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
    • TABLE 152 REST OF THE WORLD: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 153 REST OF THE WORLD: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 154 REST OF THE WORLD: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2021-2028 (USD MILLION)
    • TABLE 155 REST OF THE WORLD: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2021-2028 (USD MILLION)
    • TABLE 156 REST OF THE WORLD: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 157 REST OF THE WORLD: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
    • TABLE 158 REST OF THE WORLD: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2021-2028 (USD MILLION)

14 COMPETITIVE LANDSCAPE

  • 14.1 OVERVIEW
  • 14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • TABLE 159 OVERVIEW OF STRATEGIES ADOPTED BY KEY SLEEP APNEA ORAL APPLIANCE MANUFACTURERS
  • 14.3 REVENUE ANALYSIS
    • FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS
  • 14.4 MARKET SHARE ANALYSIS
    • FIGURE 34 MARKET SHARE ANALYSIS, 2022
  • 14.5 COMPANY EVALUATION MATRIX
    • 14.5.1 STARS
    • 14.5.2 EMERGING LEADERS
    • 14.5.3 PERVASIVE PLAYERS
    • 14.5.4 PARTICIPANTS
    • FIGURE 35 SLEEP APNEA ORAL APPLIANCES MARKET: COMPANY EVALUATION MATRIX
    • 14.5.5 COMPANY FOOTPRINT ANALYSIS
    • TABLE 160 COMPANY FOOTPRINT
    • TABLE 161 COMPANY PRODUCT FOOTPRINT
    • TABLE 162 COMPANY REGIONAL FOOTPRINT
  • 14.6 START-UP/SME EVALUATION MATRIX
    • 14.6.1 PROGRESSIVE COMPANIES
    • 14.6.2 RESPONSIVE COMPANIES
    • 14.6.3 DYNAMIC COMPANIES
    • 14.6.4 STARTING BLOCKS
    • FIGURE 36 SLEEP APNEA ORAL APPLIANCES MARKET: START-UP/SME EVALUATION MATRIX
    • 14.6.5 COMPETITIVE BENCHMARKING
    • TABLE 163 SLEEP APNEA ORAL APPLIANCES MARKET: DETAILED LIST OF KEY START-UPS/SMES
  • 14.7 COMPETITIVE SCENARIO
    • 14.7.1 PRODUCT LAUNCHES & APPROVALS
    • TABLE 164 SLEEP APNEA ORAL APPLIANCES MARKET: PRODUCT LAUNCHES & APPROVALS, 2020-2023
    • 14.7.2 DEALS
    • TABLE 165 SLEEP APNEA ORAL APPLIANCES MARKET: DEALS, 2020-2023
    • 14.7.3 OTHER DEVELOPMENTS
    • TABLE 166 SLEEP APNEA ORAL APPLIANCES MARKET: OTHER DEVELOPMENTS, 2020-2023

15 COMPANY PROFILES

  • (Business overview, Products/Solutions/Services offered, Recent Developments, MnM view, Right to win, Strategic choices, Weaknesses & competitive threats) **
  • 15.1 KEY PLAYERS
    • 15.1.1 SOMNOMED
    • TABLE 167 SOMNOMED: BUSINESS OVERVIEW
    • FIGURE 37 SOMNOMED: COMPANY SNAPSHOT (2023)
    • 15.1.2 RESMED
    • TABLE 168 RESMED: BUSINESS OVERVIEW
    • FIGURE 38 RESMED: COMPANY SNAPSHOT (2023)
    • 15.1.3 PROSOMNUS SLEEP TECHNOLOGIES
    • TABLE 169 PROSOMNUS SLEEP TECHNOLOGIES: BUSINESS OVERVIEW
    • FIGURE 39 PROSOMNUS SLEEP TECHNOLOGIES: COMPANY SNAPSHOT (2022)
    • 15.1.4 WHOLE YOU, INC.
    • TABLE 170 WHOLE YOU, INC.: BUSINESS OVERVIEW
    • 15.1.5 VIVOS THERAPEUTICS, INC.
    • TABLE 171 VIVOS THERAPEUTICS, INC.: BUSINESS OVERVIEW
    • FIGURE 40 VIVOS THERAPEUTICS, INC.: COMPANY SNAPSHOT (2022)
    • 15.1.6 OPEN AIRWAY DENTAL SOLUTIONS LTD.
    • TABLE 172 OPEN AIRWAY DENTAL SOLUTIONS LTD.: BUSINESS OVERVIEW
    • 15.1.7 PANTHERA DENTAL
    • TABLE 173 PANTHERA DENTAL: BUSINESS OVERVIEW
    • 15.1.8 AIRWAY MANAGEMENT
    • TABLE 174 AIRWAY MANAGEMENT: BUSINESS OVERVIEW
    • 15.1.9 APNEA SCIENCES
    • TABLE 175 APNEA SCIENCES: BUSINESS OVERVIEW
    • 15.1.10 DYNAFLEX
    • TABLE 176 DYNAFLEX: BUSINESS OVERVIEW
    • 15.1.11 ORAVANOSA
    • TABLE 177 ORAVANOSA: BUSINESS OVERVIEW
    • 15.1.12 MYERSON LLC
    • TABLE 178 MYERSON LLC: BUSINESS OVERVIEW
  • *Details on Business overview, Products/Solutions/Services offered, Recent Developments, MnM view, Right to win, Strategic choices, Weaknesses & competitive threats might not be captured in case of unlisted companies.
  • 15.2 OTHER PLAYERS
    • 15.2.1 MPOWRX HEALTH & WELLNESS
    • 15.2.2 THE SNORE RELIEVER COMPANY, LLC
    • 15.2.3 THE PURE SLEEP COMPANY
    • 15.2.4 TOMED GMBH
    • 15.2.5 THE AURUM GROUP
    • 15.2.6 ERKODENT ERICH KOPP GMBH
    • 15.2.7 OSCIMED SA
    • 15.2.8 SICAT GMBH & CO. KG
    • 15.2.9 GLIDEWELL
    • 15.2.10 APNOMED
    • 15.2.11 ZYPPAH
    • 15.2.12 DREAM SYSTEMS DENTAL SLEEP LABORATORY
    • 15.2.13 ALIVE MED

16 APPENDIX

  • 16.1 DISCUSSION GUIDE
  • 16.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 16.3 CUSTOMIZATION OPTIONS
  • 16.4 RELATED REPORTS
  • 16.5 AUTHOR DETAILS